Citation: | ZHANG Cui, WU Yingling, DING Jingju, WANG Sheng, GU Yu, HE Lei, JIANG Zhengju. Role of miR-34c downregulated by EBV in promoting proliferation and migration of nasopharyngeal carcinoma cells and its mechanism[J]. Journal of Bengbu Medical University, 2024, 49(1): 13-17. DOI: 10.13898/j.cnki.issn.1000-2200.2024.01.003 |
[1] |
YEW PY, MUSHIRODA T, KIYOTANI K, et al. Identification of a functional variant in SPLUNC1 associated with nasopharyngeal carcinoma susceptibility among Malaysian Chinese[J]. Mol Carcinog, 2012, 51(1): E74.
|
[2] |
SU ZY, SIAK PY, LEONG CO, et al. The role of Epstein-Barr virus in nasopharyngeal carcinoma[J]. Front Microbiol, 2023, 14: 1116143. doi: 10.3389/fmicb.2023.1116143
|
[3] |
PNG YT, YANG AZY, LEE MY, et al. The role of NK cells in EBV infection and EBV-associated NPC[J]. Viruses, 2021, 13(2): 300. doi: 10.3390/v13020300
|
[4] |
CAI LM, LYU XM, LUO WR, et al. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN[J]. Oncogene, 2015, 34(17): 2156. doi: 10.1038/onc.2014.341
|
[5] |
CUI X, SNAPPER CM. Epstein Barr virus: development of vaccines and immune cell therapy for EBV-associated diseases[J]. Front Immunol, 2021, 12: 734471. doi: 10.3389/fimmu.2021.734471
|
[6] |
DAMANIA B, KENNEY SC, RAAB-TRAUB N. Epstein-Barr virus: biology and clinical disease[J]. Cell, 2022, 185(20): 3652. doi: 10.1016/j.cell.2022.08.026
|
[7] |
LI R, ZHANG H, ZHENG X. MiR-34c induces apoptosis and inhibits the viability of M4e cells by targeting BCL2[J]. Oncol Lett, 2018, 15, 3357.
|
[8] |
BARTOSZEWSKA S, CABAJ A, BROWSKI M, et al. miR-34c-5p modulates X-box-binding protein 1 (XBP1) expression during the adaptive phase of the unfolded protein response[J]. FASEB J, 2019, 33, 11541. doi: 10.1096/fj.201900600RR
|
[9] |
XIAO SS, LI YR, PAN Q, et al. MiR-34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin-based chemotherapy[J]. J Cell Biochem, 2019, 120, 2940. doi: 10.1002/jcb.26865
|
[10] |
WANG J, LIU Y, ZHANG Y, et al. Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis[J]. Cancer Med, 2023, 12(11): 12608. doi: 10.1002/cam4.5941
|
[11] |
赵光, 朱天霸, 许儒, 等. 基于SEER数据库建立鼻咽癌预后预测模型列线图[J]. 徐州医科大学学报, 2022, 42(3): 217. https://www.cnki.com.cn/Article/CJFDTOTAL-XZYX202203012.htm
|
[12] |
AHMED N, ABUSALAH M, FARZAND A, et al. Updates on Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma: emphasis on the latent gene products of EBV[J]. Medicina (Kaunas), 2022, 59(1): 2. doi: 10.3390/medicina59010002
|
[13] |
XU S, ZHOU Z, PENG X, et al. EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma[J]. Cell Death Dis, 2021, 12(4): 344. doi: 10.1038/s41419-021-03639-2
|
[14] |
ZHU Q, ZHANG Q, GU M, et al. MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma[J]. Autophagy, 2021, 17(7): 1667. doi: 10.1080/15548627.2020.1781368
|
[15] |
GUO R, LIANG JH, ZHANG Y, et al. Methionine metabolism controls the B cell EBV epigenome and viral latency[J]. Cell Metab, 2022, 34(9): 1280. doi: 10.1016/j.cmet.2022.08.008
|
[16] |
MA YX, ZHANG H, LI XH, et al. MiR-30e-5p inhibits proliferation and metastasis of nasopharyngeal carcinoma cells by targeting USP22[J]. Eur Rev Med, Pharmacol, 2018, 22, 6342.
|
[17] |
KRAMER N, WALZL A, UNGER C, et al. In vitro cell migration and invasion assays[J]. Mutat Res, 2013, 752: 10. doi: 10.1016/j.mrrev.2012.08.001
|
[18] |
DUFF D, LONG A. Roles for RACK1 in cancer cell migration and invasion[J]. Cell. Signal, 2017, 35, 250. doi: 10.1016/j.cellsig.2017.03.005
|
[19] |
MENDEZ MG, KOJIMA S, GOLDMAN RD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition[J]. FASEB J, 2010, 24, 1838. doi: 10.1096/fj.09-151639
|
[20] |
SANG Y, CHENG C, ZENG YX, et al. Snail promotes metastasis of nasopharyngeal carcinoma partly by down-regulating TEL2[J]. Cancer Communications (London, England), 2018, 38: 58.
|
[21] |
LI Y, YANG X, DU X, et al. RAB37 hypermethylation regulates metastasis and resistance to docetaxel-based induction chemotherapy in nasopharyngeal carcinoma[J]. Clin Cancer Res, 2018, 24: 6495. doi: 10.1158/1078-0432.CCR-18-0532
|
[22] |
DU ZM, HU CF, SHAO Q, et al. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients[J]. Int J Cancer, 2019, 125: 1832.
|
[23] |
KUMAR B, KOUL S, PETERSEN J, et al. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity[J]. Cancer Res, 2010, 70(2): 832. doi: 10.1158/0008-5472.CAN-09-2918
|
[24] |
YANG J, LV X, CHEN J, et al. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway[J]. Oncotarget, 2016, 7(13): 15632. doi: 10.18632/oncotarget.6695
|
[25] |
YAN Q, ZENG Z, GONG Z, et al. Ebv-mir-bart10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC[J]. Oncotarget, 2015, 6(39): 41766. doi: 10.18632/oncotarget.6155
|
1. |
李斯淼,陈芳敏,方丽,季新奇,夏琬婷,史孟雄,李佳璇,王馨蒂. 一株家蚕肠道分离乳酸菌的鉴定及生物学特性. 微生物学通报. 2025(02): 771-784 .
![]() | |
2. |
徐春梅,朱有根,雷萌,徐荣. 2岁以下呼吸道感染患儿肺炎链球菌、流感嗜血杆菌携带检出率及耐药性分析. 中国医学创新. 2024(34): 153-157 .
![]() |